Avino Silver & Gold Mines Ltd. Reports Q3 2026 Financial Results
Avino Silver & Gold Mines Ltd. announced its unaudited financial results for the third quarter of 2026, reporting $33.4 million in revenues.
Stocks · News reference
Avino Silver & Gold Mines Q3 2026 Earnings Call Transcript
Avino Silver & Gold Mines (AMEX:ASM) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
ASM International Announces Nomination of Denise Koopmans to Supervisory Board
ASM International N.V. has announced its intention to nominate Denise Koopmans for appointment to its Supervisory Board, with a formal vote expected at an Extraordinary General Meeting in early 2027.
Avino Silver & Gold Mines Ltd. Reports Results from 2026 La Preciosa Drill Program
Avino Silver & Gold Mines Ltd. announced results from thirteen drill holes completed during the first phase of its 2026 infill drilling program at the La Preciosa property in Durango, Mexico.
H.C. Wainwright Maintains Buy Rating on Avino Silver & Gold Mines
Analyst Heiko Ihle of H.C. Wainwright has reaffirmed a 'Buy' rating and a $10.50 price target for Avino Silver & Gold Mines.
Roth Capital Upgrades Avino Silver & Gold Mines to Buy, Lowers Price Target to $7
Roth Capital analyst Joe Reagor upgrades Avino Silver & Gold Mines (AMEX:ASM) from Neutral to Buy and lowers the price target from $8 to $7.
Ladder Capital Posts Upbeat Q3 Earnings, Joins Alcoa, Hyster-Yale And Other Big Stocks Moving Higher On Friday
U.S. stocks were mixed; Ladder Capital surged after beating Q3 estimates. Alcoa and other stocks also gained, led by Strata Critical Medical’s 7.5% rise.